Skip to main content
  • Clinical
      |Clinical
    • Acute Coronary Syndromes
    • Cardiac Surgery
    • Covid-19
    • Heart Failure
    • Heart Health
    • Heart Rhythm
    • Hypertension
    • Interventional Cardiology
    • Mitral Valve
    • Pharmaceutics
    • Structural Heart Disease
    • TAVR
    • Tricuspid Valve
    • Vascular & Endovascular
  • Management
      |Management
    • Chest Pain Guidelines
    • Compensation
    • Economics
    • Education & Training
    • Legal News
    • Patient Care
    • Policy & Regulations
    • Professional Associations
    • Quality
    • Revenue
    • Staffing
  • Technology
      |Technology
    • AI
    • Cardiac Imaging
    • Cath Lab
    • CT
    • CVIS
    • ECG
    • Echo
    • EP Lab
    • Informatics
    • MRI
    • Nuclear Cardiology
    • Remote Monitoring
  • Videos
  • Conferences
      |Conferences
    • ACC
    • AHA
    • ASE
    • ASNC
    • ESC
    • EuroPCR
    • HFSA
    • HRS
    • SCAI
    • SCCT
    • SIIM
    • SNMMI
    • STS
    • TCT
    • VIVA
  • Custom Content
      |Custom Content
    • Experience Stories
    • Webinars & Videos
  • Subscribe
  • Forty Under 40 Award
      |Forty Under 40 Award
    • Class of 2026
    • Class of 2025

Search form

Home

Hydroxychloroquine, azithromycin & “potentially lethal” cardiovascular complications | Tele-echocardiography for HF

News You Need to Know Today
Hydroxychloroquine, azithromycin & “potentially lethal” cardiovascular complications | Tele-echocardiography for HF
Wednesday, May 27, 2020
Link to Twitter Link to Facebook Link to Linkedin Link to Vimeo

Today's News and Trends

Top Stories

Hydroxychloroquine, azithromycin linked to “potentially lethal” cardiovascular complications

Hydroxychloroquine and azithromycin are both associated with significant cardiovascular complications, and taking them together could be a deadly combination, according to new research published in Circulation.

READ MORE >
Share on Twitter Share on Facebook Share on Linkedin

Hydroxychloroquine, azithromycin linked to “potentially lethal” cardiovascular complications

Share on Twitter Share on Facebook Share on Linkedin
Hydroxychloroquine and azithromycin are both associated with significant cardiovascular complications, and taking them together could be a deadly combination, according to new research published in Circulation.
READ MORE >

Heart transplants provide value for patients with AL, ATTR cardiac amyloidosis

With the disease becoming more and more common in the United States, researchers have been hard at work determining the best possible treatment options.

READ MORE >
transplant.jpg
Share on Twitter Share on Facebook Share on Linkedin

Heart transplants provide value for patients with AL, ATTR cardiac amyloidosis

Share on Twitter Share on Facebook Share on Linkedin
transplant.jpg
With the disease becoming more and more common in the United States, researchers have been hard at work determining the best possible treatment options.
READ MORE >

Tele-echocardiography earns high marks as a heart failure treatment

Telemedicine is gaining popularity all over the world, but it makes more sense for some specialties than others.

READ MORE >
Share on Twitter Share on Facebook Share on Linkedin

Tele-echocardiography earns high marks as a heart failure treatment

Share on Twitter Share on Facebook Share on Linkedin
Telemedicine is gaining popularity all over the world, but it makes more sense for some specialties than others.
READ MORE >

Featured Articles

Selatogrel provides heart attack patients with a lightning-fast antiplatelet response

A single dose of selatogrel can safely provide heart attack patients with a “profound, rapid” antiplatelet response, according to a new study published in the Journal of the American College of Cardiology.

READ MORE >
Share on Twitter Share on Facebook Share on Linkedin

Selatogrel provides heart attack patients with a lightning-fast antiplatelet response

Share on Twitter Share on Facebook Share on Linkedin
A single dose of selatogrel can safely provide heart attack patients with a “profound, rapid” antiplatelet response, according to a new study published in the Journal of the American College of Cardiology.
READ MORE >

Stroke rates are low among COVID-19 patients—but when they occur, the risk of death is substantial

The study’s authors tracked more than 3,500 hospitalized COVID-19 patients who received treatment in New York City in March and April 2020. 

READ MORE >
Hypertension patients measured their blood pressure less frequently during the early months of the COVID-19 pandemic, according to new research published in Hypertension. In addition, when those patients did measure their blood pressure, the readings were less healthy than they had been before the pandemic.
Share on Twitter Share on Facebook Share on Linkedin

Stroke rates are low among COVID-19 patients—but when they occur, the risk of death is substantial

Share on Twitter Share on Facebook Share on Linkedin
Hypertension patients measured their blood pressure less frequently during the early months of the COVID-19 pandemic, according to new research published in Hypertension. In addition, when those patients did measure their blood pressure, the readings were less healthy than they had been before the pandemic.
The study’s authors tracked more than 3,500 hospitalized COVID-19 patients who received treatment in New York City in March and April 2020. 
READ MORE >

Evolocumab improves cardiovascular outcomes for patients with a recent MI

Evolocumab is an effective treatment option for patients with a recent myocardial infarction (MI), according to new findings published in JAMA Cardiology.

READ MORE >
Share on Twitter Share on Facebook Share on Linkedin

Evolocumab improves cardiovascular outcomes for patients with a recent MI

Share on Twitter Share on Facebook Share on Linkedin
Evolocumab is an effective treatment option for patients with a recent myocardial infarction (MI), according to new findings published in JAMA Cardiology.
READ MORE >

In Other News

RSNA 2020 annual meeting will be held virtually amid COVID-19 concerns

Since its inception, RSNA's in-person annual meeting has only been canceled twice, in 1943 and 1945, due to transportation and gasoline supply issues during and immediately following World War II.

READ MORE >
RSNA 2019
Share on Twitter Share on Facebook Share on Linkedin

RSNA 2020 annual meeting will be held virtually amid COVID-19 concerns

Share on Twitter Share on Facebook Share on Linkedin
RSNA 2019
Since its inception, RSNA's in-person annual meeting has only been canceled twice, in 1943 and 1945, due to transportation and gasoline supply issues during and immediately following World War II.
READ MORE >

North Dakota has the best health infrastructure during the COVID-19 pandemic

WalletHub compared the 50 states on 14 unique metrics to determine which had the best health infrastructures to deal with the COVID-19 pandemic.

READ MORE >
COVID clinician
Share on Twitter Share on Facebook Share on Linkedin

North Dakota has the best health infrastructure during the COVID-19 pandemic

Share on Twitter Share on Facebook Share on Linkedin
COVID clinician
WalletHub compared the 50 states on 14 unique metrics to determine which had the best health infrastructures to deal with the COVID-19 pandemic.
READ MORE >

Innovate Healthcare thanks our partners for supporting our newsletters.
Sponsorship has no influence on editorial content.

Interested in reaching our audiences, contact our team

*|LIST:ADDRESSLINE|*

You received this email because you signed up for newsletters from Innovate Healthcare.
Change your preferences or unsubscribe here

Contact Us  |  Unsubscribe from all  |  Privacy Policy

© Innovate Healthcare, a TriMed Media brand
Innovate Healthcare

Recent Newsletters

TAVR Highlights: Self-expanding valves continue to impress | A new technique | Why implant depth matters | SAPT vs. DAPT
Recall announced after 3 injuries | Medical societies respond to government report | New-look pacemaker requires no implant
Is coffee bad for the heart? | FDA approves new hypertension drug | Stolen devices sold to patients | BP drug recalled
OIG questions vascular procedures | Things to consider before signing your next contract | Is coffee bad for the heart?
Looking Back: Cardiovascular care hit by major recalls | New payment model on the way | SMART update | Trends in cardiac CT
Another Impella warning | Devices stolen, sold to patients | FDA impressed by new AI software | SAPT after TAVR
Week in Review: FDA confirms recall for vascular device | BATMAN to the rescue | Prasugrel after PCI | GLP-1 drugs & AFib

Pagination

    • Current page 1
    • Page 2
    • Page 3
    • Page 4
    • Page 5
    • Page 6
    • Page 7
    • Page 8
    • Page 9 …
    • Next page ››
    • Last page Last »
  • Home
  • News
  • Article Archive
  • Custom Content
  • Webinars
  • Press Releases
  • Content Studio
  • Advertising
  • Submit Press Release
  • Contact Us
  • Terms of Use
  • Privacy Policy
  • Cardiovascular Business
  • HealthExec
  • Radiology Business
 
© 2026 Innovate Healthcare | All Rights Reserved. | Terms of Use | Privacy Policy
 
Design by Adaptive Theme